-
1.Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan. Acta Paediatr. 2020 (in press).
Iio K, Uda K, Miura M, et al.
-
2.Real-world safety and effectiveness of infliximab in pediatric patients with acute Kawasaki disease: A postmarketing surveillance in Japan (SAKURA Study). Pediatr Infect Dis J. 2020;39:41-47.
Miura M, Kobayashi T, Igarashi T, et al.
-
3.The impact of changes in clinical guideline on practice patterns and healthcare utilizations for Kawasaki disease in Japan. Front Pediatr. 2020;8:114.
Okubo Y, Miura M, Kobayashi T, et al.
-
4.Cardiofaciocutaneous syndrome with KRAS gene mutation presenting as chylopericardium. Am J Med Genet A. 2020;182:532-535.
Akahoshi S, Hirano A, Miura M, et al.
-
5.Decreased hemoglobin after initial treatment is associated with treatment resistance in Kawasaki disease in Kobayashi risk stratification. World J Pediatr. 2020;16:623-628.
Atsumi Y, Sakakibara H, Miura M, et al.
-
6.Acute rheumatic fever and Kawasaki disease occurring in a single patient. Front Pediatr. 2020;8:562.
Iio K, Fukushima N, Miura M, et al.
-
7.Clinical and structural aspects of tracheal stenosis and a novel embryological hypothesis of left pulmonary artery sling. Pediatr Pulmonol. 2020;55:747-753.
Fukushima N, Shimojima N, Miura M, et al.
-
8.Flecainide improves cardiac synchronization in an early infant with Wolff-Parkinson-White syndrome with left ventricular dyssynchrony. J Cardiol Cases. 2020;22:1-4.
Sumitomo NF, Fukushima N, Miura M.
-
9.Successful endocardial catheter ablation of a drug-resistant monomorphic ventricular tachycardia in a child with Brugada syndrome. HeartRhythm Case Rep. 2020;6:641-645.
Nabeshima T, Sumitomo N, Miura M, et al.
-
10.Prolonged PR interval in a patient with acute rheumatic fever. QJM. 2019;112(10):817-818.
Uda K, Horikoshi Y, Miura M.
-
11.Mode of death and predictors of mortality in adult Fontan survivors: A Japanese multicenter observational study. Int J Cardiol. 2019;276:74-80.
Ohuchi H, Inai K, Miura M, et al.
-
12.Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. Lancet Child Adolesc Health. 2018;2:855-862.
Miyata K, Kaneko T, Miura M, et al.
-
13.Association of severity of coronary artery aneurysms in patients With Kawasaki disease and risk of later coronary events. JAMA Pediatr. 2018;172:e180030.
Miura M, Kobayashi T, Kaneko T, et al.
-
14.Nebulized hypertonic saline in infants hospitalized with moderately severe bronchiolitis due to RSV infection: A multicenter randomized controlled trial. Pediatr Pulmonol. 2018;53:358-365.
Morikawa Y, Miura M, Furuhata MY, et al.
-
15.Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease. Acta Paediatr. 2018;107:1049-1054.
Kawai R, Nomura O, Tomobe Y, et al.
-
16.Bradycardia associated with prednisolone in children with severe Kawasaki disease. J Pediatr. 2017;185:106-111.e1.
Nagakura A, Morikawa Y, Miura M, et al.
-
17.Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. J Cardiol. 2017;70:232-237.
Sumitomo N, Horigome H, Miura M, et al.
-
18.Nationwide survey of patients with giant coronary aneurysm secondary to Kawasaki disease 1999-2010 in Japan. 2017;82:239-246.
Fukazawa R, Kobayashi T, Miura M, et al.
-
19.Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors. Eur J Pediatr. 2016;175:631-637. Hayakawa I, Miura M. Giant coronary aneurysms in incomplete Kawasaki disease With early spontaneous defervescence. J Clin Rheumatol. 2016;22:40.
Terano C, Ishikura K, Miura M, et al.
-
20.Patient-specific human induced pluripotent stem cell model assessed with electrical pacing validates S107 as a potential therapeutic agent for catecholaminergic polymorphic ventricular tachycardia. PLoS One. 2016;11:e0164795.
Sasaki K, Makiyama T, Miura M, et al.
-
21.A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants. Eur J Pediatr. 2016;175:1129-1132.
Fukushima N, Nanao K, Miura M, et al.
-
22.Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study. Pediatr Rheumatol Online J. 2015;13:44.
Takahashi T, Sakakibara H, Miura M, et al.
-
1. 三浦 大,前田 潤,編集.はじめて学ぶ小児循環器(改訂第2版).診断と治療社,2020.
-
2. 三浦 大.川崎病-増え続ける謎の小児疾患.弘文堂,2019.
-
3.日本川崎病学会(編集代表).川崎病学.診断と治療社,2018.